Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

BACKGROUND: Lack of biomarkers for treatment selection and monitoring in small cell lung cancer (SCLC) patients with the limited therapeutic options, result in poor outcomes. Therefore, new prognostic biomarkers are needed to improve their management. The prognostic value of cell-free DNA (cfDNA) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondelo-Macía, Patricia, García-González, Jorge, Abalo, Alicia, Mosquera-Presedo, Manuel, Aguín, Santiago, Mateos, María, López-López, Rafael, León-Mateos, Luis, Muinelo-Romay, Laura, Díaz-Peña, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641037/
https://www.ncbi.nlm.nih.gov/pubmed/36386449
http://dx.doi.org/10.21037/tlcr-22-273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641037/
https://www.ncbi.nlm.nih.gov/pubmed/36386449
http://dx.doi.org/10.21037/tlcr-22-273

Ejemplares similares